These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 3495843)

  • 1. [Adoptive immunotherapy: a new therapeutic approach to cancer based on interleukin 2].
    Sculier JP; Bron D; Delforge A; Stryckmans P; Klastersky J
    Rev Med Brux; 1987 Mar; 8(3):133-9. PubMed ID: 3495843
    [No Abstract]   [Full Text] [Related]  

  • 2. Adoptive immunotherapy of cancer using lymphokine activated killer cells and recombinant interleukin-2.
    Rosenberg SA
    Important Adv Oncol; 1986; ():55-91. PubMed ID: 3330541
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of malignant tumors by interleukin 2 and LAK cells].
    Degos L
    Nouv Rev Fr Hematol (1978); 1988; 30(1-2):119-22. PubMed ID: 3260373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The adoptive immunotherapy of cancer using lymphokine activated killer cells and recombinant interleukin-2.
    Ettinghausen SE; Rosenberg SA
    Springer Semin Immunopathol; 1986; 9(1):51-71. PubMed ID: 3523804
    [No Abstract]   [Full Text] [Related]  

  • 5. Adoptive immunotherapy in gastrointestine malignancies using interleukin-2. Current results and future prospects.
    Marshall GD
    Acta Chir Scand Suppl; 1989; 549():71-4. PubMed ID: 2784605
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of interleukin 2-activated lymphocytes (LAK cells) in adoptive immunotherapy of neoplasms].
    Robak T
    Pol Tyg Lek; 1988 Nov; 43(47):1491-5. PubMed ID: 3266975
    [No Abstract]   [Full Text] [Related]  

  • 7. Interleukin-2 and lymphokine-activated killer cell therapy for gastrointestinal cancer.
    Guillou P
    Acta Chir Scand Suppl; 1989; 549():26-30. PubMed ID: 2784604
    [No Abstract]   [Full Text] [Related]  

  • 8. [Adoptive immunotherapy of malignant diseases using normal allogeneic LAK cells].
    Kimoto Y; Tanji Y; Tanaka T; Taguchi T
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1884-9. PubMed ID: 3496050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The activation of natural killer cells. A new approach to adoptive immunotherapy of tumors].
    Schwarz R
    Fortschr Med; 1988 Oct; 106(29):579-80. PubMed ID: 3266178
    [No Abstract]   [Full Text] [Related]  

  • 10. "Lymphokine activated killing" as treatment for human cancer: clinical extrapolations from laboratory studies with interleukin-2 expanded leukocytes.
    Sondel PM; Hank JA; Kohler PC; Chen BP; Sosman J
    Prog Clin Biol Res; 1989; 288():151-60. PubMed ID: 2654949
    [No Abstract]   [Full Text] [Related]  

  • 11. Lymphokine-activated killer cells: a new approach to immunotherapy of cancer.
    Rosenberg S
    J Natl Cancer Inst; 1985 Oct; 75(4):595-603. PubMed ID: 3876465
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunological effects of adoptive immunotherapy with IL-2: an overview.
    Kradin R; Yamin R; Kurnick J
    Pathol Immunopathol Res; 1988; 7(6):434-41. PubMed ID: 3070529
    [No Abstract]   [Full Text] [Related]  

  • 13. [Using LAK cells in the adoptive immunotherapy in cancers].
    Urushizaki I
    Rinsho Ketsueki; 1987 Oct; 28(10):1897-8. PubMed ID: 3502569
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful immunotherapy of murine experimental hepatic metastases with lymphokine-activated killer cells and recombinant interleukin 2.
    Lafreniere R; Rosenberg SA
    Cancer Res; 1985 Aug; 45(8):3735-41. PubMed ID: 3893689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphokine activated killer cells research in China.
    Ba DN
    Proc Chin Acad Med Sci Peking Union Med Coll; 1988; 3(3):170-4. PubMed ID: 3064089
    [No Abstract]   [Full Text] [Related]  

  • 16. [A new approach to immunotherapy of cancer based on autologous T-lymphocytes].
    Dosne Pasqualini C; Laguens RP
    Medicina (B Aires); 1987; 47(3):307-12. PubMed ID: 3326997
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of new immunologic approaches to cancer therapy.
    Rosenberg SA
    Blood Purif; 1988; 6(2):69-76. PubMed ID: 3293619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interleukin 2].
    Taguchi T; Kimoto Y
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1203-7. PubMed ID: 3495239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adoptive immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes].
    van de Loosdrecht AA; Ossenkoppele GJ; Beelen RH
    Ned Tijdschr Geneeskd; 1989 Oct; 133(40):1994-5. PubMed ID: 2812087
    [No Abstract]   [Full Text] [Related]  

  • 20. Adoptive immunotherapy of malignant diseases with IL-2-activated lymphocytes.
    Kimoto Y; Taguchi T
    Biken J; 1987 Jun; 30(2):29-38. PubMed ID: 3501954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.